Skip to main content

KHS Commissions 750 kWp Solar Plant at Ahmedabad Factory, Cutting Grid Dependency to 20%

Image
KHS Commissions 750 kWp Solar Plant at Ahmedabad Factory, Cutting Grid Dependency to 20%

SHERIDAN, WYOMING -- June 15, 2026 -- KHS Group has commissioned a 750.2 kWp photovoltaic system at its production site in Ahmedabad, India, generating 1,100 MWh of green electricity per year and covering approximately 80% of the facility's energy requirement. The plant went into operation in early March 2026 following a three-month installation phase and is projected to save up to 1,000 metric tons of indirect carbon emissions annually. The investment advances KHS's group-wide target of reducing scope 1 and 2 greenhouse gas emissions by 36% by 2028.

Roche Wins FDA Approval for First IHC Companion Diagnostic to Detect PTEN Protein Loss in Prostate Cancer

Image
FDA Grants Priority Review for Roche's Tecentriq in Stage III dMMR Colon Cancer After Surgery

SHERIDAN, WYOMING -- June 15, 2026 -- Roche has received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the first immunohistochemistry companion diagnostic cleared to assess PTEN protein loss in patients with prostate adenocarcinoma. The assay identifies patients whose tumours exhibit PTEN deficiency, making them potentially eligible for treatment with AstraZeneca's TRUQAP in combination with abiraterone acetate. Approval is based on results from the CAPItello-281 clinical study, where the assay served as the enrollment diagnostic to identify patients with PTEN-deficient tumours.

FDA Grants Priority Review for Roche's Tecentriq in Stage III dMMR Colon Cancer After Surgery

Image
FDA Grants Priority Review for Roche's Tecentriq in Stage III dMMR Colon Cancer After Surgery

SHERIDAN, WYOMING -- June 15, 2026 -- The U.S. Food and Drug Administration has accepted Roche's supplemental Biologics License Application for Tecentriq and Tecentriq Hybreza in combination with chemotherapy as an adjuvant treatment for stage III dMMR/MSI-H colon cancer following surgery. The FDA has granted Priority Review and is expected to issue a decision by October 9, 2026. The filing is supported by Phase III ATOMIC study data showing a 50% reduction in the risk of disease recurrence or death compared to chemotherapy alone, results published in The New England Journal of Medicine.

Dentsply Sirona Launches WaveOne® Gold Orifice Shaper for Single-Motor Coronal Flaring in the U.S. and Canada

Image
Dentsply Sirona Launches WaveOne® Gold Orifice Shaper for Single-Motor Coronal Flaring in the U.S. and Canada

SHERIDAN, WYOMING -- June 15, 2026 -- Dentsply Sirona has launched the WaveOne® Gold Orifice Shaper, its first reciprocating coronal flaring instrument, now available in the United States and Canada. The file is designed to integrate directly into the existing WaveOne® Gold treatment protocol, using the same reciprocating motion and motor settings as the rest of the system. That compatibility eliminates the need to change motor configurations during root canal preparation — a practical workflow improvement that reduces procedural complexity and the risk of operator error.

Sidel Brings rPET Integration, Robotics, and Digital Line Intelligence to Fispal Tecnologia 2026

Image
Sidel Brings rPET Integration, Robotics, and Digital Line Intelligence to Fispal Tecnologia 2026

SHERIDAN, WYOMING -- June 15, 2026 -- Sidel will exhibit at Fispal Tecnologia 2026 in São Paulo from June 16 to 19, presenting packaging line innovations tailored to the Latin American food and beverage market. The company's stand K104 at São Paulo Expo will feature live demonstrations of palletising robotics, laser-blown PET bottle technology, and its cloud-based line performance suite. The exhibit reflects more than three decades of Sidel's operational presence in Brazil, where FMCG manufacturers face accelerating pressure to integrate recycled materials without sacrificing throughput.

GS1 Germany and Yagora Launch Online Briefing on the Future of Category Management

Image
GS1 Germany and Yagora Launch Online Briefing on the Future of Category Management

SHERIDAN, WYOMING -- June 15, 2026 -- GS1 Germany and Yagora GmbH are jointly hosting a free, hour-long online session on June 24, 2026, focused on the future direction of category management and shopper marketing. The session targets category managers, trade marketing professionals, and data and analytics specialists working in retail. Attendees will receive applied strategic input on the fastest-growing retail categories, point-of-sale insights translation, and practical promotional guidance drawn from both food and non-food environments.

Philips VeriSight Pro 3D ICE Brings Real-Time Imaging Inside the Heart to Advance Minimally Invasive Structural Procedures

Image
Philips VeriSight Pro 3D ICE Brings Real-Time Imaging Inside the Heart to Advance Minimally Invasive Structural Procedures

SHERIDAN, WYOMING -- June 9, 2026 -- Philips has put its VeriSight Pro 3D intracardiac echocardiography (ICE) technology in front of a wider audience through a feature on the BBC's technology program Tech Now, filmed during a live structural heart procedure in Copenhagen. The technology places a miniature ultrasound probe on the tip of a catheter, threading it through a vein into the heart to deliver real-time three-dimensional images of anatomy, valves, and treatment devices. For interventional teams, it offers an alternative to passing a larger probe down the patient's esophagus under general anaesthesia. The result is a more precise and less invasive route to treating structural heart disease.

Philips Future Health Index 2026 Finds AI Saving Clinicians 16 Working Days a Year as Training Gaps Persist

Image
Philips Future Health Index 2026 Finds AI Saving Clinicians 16 Working Days a Year as Training Gaps Persist

SHERIDAN, WYOMING -- June 9, 2026 -- Philips has released its Future Health Index 2026, the 11th edition of its annual global study, drawing on responses from more than 2,000 healthcare professionals and over 20,000 patients across 10 countries. The findings show that artificial intelligence already saves clinicians the equivalent of more than 16 working days each year and is helping many of them treat additional patients. At the same time, the report warns that inadequate training and fragmented IT infrastructure could leave some health systems behind. For hospital leaders and care providers, the results frame AI less as a future prospect and more as an operational tool already reshaping daily workloads.

Eurobike Builds Its 2026 Program Around the 32-Inch Wheel Debate

Image
Eurobike Builds Its 2026 Program Around the 32-Inch Wheel Debate

SHERIDAN, WYOMING -- June 8, 2026 -- Eurobike will turn one of cycling's most contested engineering questions into a centerpiece of its 2026 program. The trade fair, organized by Fairnamic GmbH, plans to showcase 32-inch wheel concepts for gravel and mountain bikes across its exhibition floor and a series of expert sessions before the show opens in Frankfurt on June 24. For component makers, frame developers and buyers, the move offers a working venue to weigh whether larger diameters move from prototype to standard. It also positions the event as a reference point for an industry still deciding where wheel sizes go next.

Ivoclar Publishes Three Clinical Tips for Combining Tetric plus Flow and Fill in Anterior and Class V Restorations

Image
Ivoclar Publishes Three Clinical Tips for Combining Tetric plus Flow and Fill in Anterior and Class V Restorations

SHERIDAN, WYOMING -- June 7, 2026 -- Ivoclar has published clinical practice guidance for dental professionals working with the Tetric plus composite system, focusing on combined workflows involving Tetric plus Flow and Tetric plus Fill in anterior restorations. The guidance positions Tetric plus Flow as a single-material replacement for both Tetric EvoFlow and Tetric PowerFlow, built around its thixotropic properties — controlled, precise application alongside strong flow when required. Three tips address contouring support, surface imperfection repair and volume or transition adjustment in Class IV, Class V and direct veneer procedures. OptraSculpt Pad and OptraGloss are recommended as supporting instruments throughout.